Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Epilepsy & Behavior : E&B|June 21, 2014
Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndromeDwain Tolbert, Stuart I Harris, Ihor Bekersky, et al.
Journal of Clinical Pharmacology|June 14, 2001
Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjectsI Bekersky, D Dressler, A Alak, et al.
Clinical Therapeutics|September 30, 2017
A Thorough QT/QTc Study of Clobazam in Healthy VolunteersDwain Tolbert, Judy Gordon, Stuart Harris, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in ratsG W Boswell, I Bekersky, D Buell, et al.
The Journal of Clinical Investigation|August 1, 1971
Bile acid synthesis in the isolated, perfused rabbit liverE H Mosbach, M A Rothschild, I Bekersky, et al.
Journal of the American Academy of Dermatology|January 6, 2001
Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitisI Bekersky, W Fitzsimmons, A Tanase, et al.
Journal of Clinical Pharmacology|February 13, 1999
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteersM F Hebert, R M Fisher, C L Marsh, et al.
Pageof 8